The GMO co-founder explains why most investing “premiums” boil down to value—and why AI’s promise doesn’t spare it from a painful shakeout.
The GMO co-founder explains why most investing “premiums” boil down to value—and why AI’s promise doesn’t spare it from a painful shakeout.